Markets:

Overview

News

Currencies

International

Treasuries

Olema Pharmaceuticals, Inc. - Common Stock (NQ:OLMA)

25.36 +0.35 (+1.40%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Olema Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Olema Oncology to Participate at Upcoming Investor Conferences

February 21, 2023

From Olema Oncology

Via GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 02, 2023

From Olema Oncology

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 17, 2023

Via Benzinga

Olema Pharma Says Lead Candidate Robust Activity In Breast Cancer Patients ↗

October 26, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 12, 2023

Via Benzinga

CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks ↗

January 06, 2023

Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too.

Via Investor's Business Daily

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 04, 2023

From Olema Oncology

Via GlobeNewswire

Olema Oncology to Present at 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

From Olema Oncology

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 07, 2022

Via Benzinga

Olema Oncology Announces OP-1250 Demonstrates Attractive Combinability with CDK 4/6 Inhibitor Palbociclib in Phase 1b Dose Escalation Study

December 07, 2022

From Olema Oncology

Via GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 02, 2022

From Olema Oncology

Via GlobeNewswire

Olema Oncology Announces Poster Presentations at the 2022 San Antonio Breast Cancer Symposium (SABCS)

November 21, 2022

From Olema Oncology

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 15, 2022

Via Benzinga

Olema Oncology Reports Third Quarter 2022 Financial Results and Provides Corporate Update

November 08, 2022

From Olema Oncology

Via GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 02, 2022

From Olema Oncology

Via GlobeNewswire

Olema Oncology to Present at Upcoming Investor Conferences in November

November 01, 2022

From Olema Oncology

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 31, 2022

Gainers PLx Pharma (NASDAQ:PLXP) stock increased by 15.5% to $0.7 during Monday's pre-market session. The market value of their outstanding shares is at $20.3 million.

Via Benzinga

Olema Oncology Announces Complete ER Antagonist OP-1250 Continues to Demonstrate Robust Activity in Phase 1/2 Clinical Trial

October 26, 2022

From Olema Oncology

Via GlobeNewswire

Olema Oncology Announces Upcoming Clinical Data Poster Presentation at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

October 12, 2022

From Olema Oncology

Via GlobeNewswire

Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday ↗

October 21, 2022

Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

October 10, 2022

We're starting off the trading week with a look at the biggest pre-market stock movers for Monday morning and the news moving them!

Via InvestorPlace

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 04, 2022

From Olema Oncology

Via GlobeNewswire

Recap of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 09, 2022

Via Benzinga

Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners ↗

July 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday ↗

August 11, 2022

Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.

Via Benzinga

This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday ↗

July 25, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 21, 2022

Via Benzinga

This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday ↗

July 22, 2022

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period...

Via Benzinga

Olema Oncology Shares Ascend As FDA Grants Fast Track Status To Breast Cancer Candidate ↗

July 21, 2022

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Olema Oncology’s (NASDAQ: OLMA) lead asset OP-1250 for the treatment of ER-positive (ER+), human epidermal growth...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 10, 2022 ↗

June 10, 2022

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Olema Pharmaceuticals, Inc. - Common Stock (NQ:OLMA)

All News about Olema Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today